Central serous retinopathy associated with topical oral corticosteroid use: a case report

被引:4
作者
O'Brien, Preston [1 ]
Young, Ryan C. [1 ,2 ]
Ghafoori, Shelley Day [1 ,2 ]
Harper, C. Armitage [1 ,2 ]
Wong, Robert W. [1 ,2 ]
机构
[1] Austin Retina Associates, 801 W 38th St,Suite 200, Austin, TX 78705 USA
[2] Univ Texas Austin, Dell Med Sch, Dept Surg & Perioperat Care, Austin, TX 78712 USA
关键词
Pigment epithelial detachment; Central serous chorioretinopathy; Fluocinonide; Topical oral gel; CHORIORETINOPATHY; GLUCOCORTICOIDS;
D O I
10.1186/s13256-019-2143-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Oral topical corticosteroid gels are widely used in dental medicine. Case studies of central serous retinopathy have been reported following administration of corticosteroids, but none so far coinciding with the use of topical fluocinonide gel. This case report further contributes to the database of potential risks of corticosteroid use. Case presentation A 40-year-old South Asian woman presented with decreased vision, pigment epithelial detachments, and serous retinal detachments in both eyes 1 month after starting treatment with topical fluocinonide 0.05%, a topical oral corticosteroid gel. Her condition resolved 6 months after discontinuing the use of the steroid. Conclusions To the best of our knowledge, this is the first case of idiopathic central serous retinopathy associated with the use of oral fluocinonide gel. Discontinuing the use of the steroid may result in resolution of the serous retinal detachment and improvement of visual symptoms. Patients and their doctors who prescribe this medication should be aware of this association.
引用
收藏
页数:6
相关论文
共 31 条
[11]   Central serous chorioretinopathy associated with topical dermal corticosteroids [J].
Fernandez, CF ;
Mendoza, AJ ;
Arevalo, JF .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2004, 24 (03) :471-474
[12]  
GASS JDM, 1977, T AM ACAD OPHTHALMOL, V83, P456
[13]  
George Saranya, 2018, Indian J Dent Res, V29, P107, DOI 10.4103/ijdr.IJDR_694_16
[14]   Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids [J].
Haimovici, R ;
Gragoudas, ES ;
Duker, JS ;
Sjaarda, RN ;
Eliott, D .
OPHTHALMOLOGY, 1997, 104 (10) :1653-1660
[15]   6 CASES OF CENTRAL SEROUS CHOROIDOPATHY INDUCED BY SYSTEMIC CORTICOSTEROID-THERAPY [J].
HARADA, T ;
HARADA, K .
DOCUMENTA OPHTHALMOLOGICA, 1985, 60 (01) :37-44
[16]  
Hussain Deeba, 1998, Indian Journal of Ophthalmology, V46, P131
[17]   RESULTS OF 1-YEAR FOLLOW-UP EXAMINATIONS AFTER INTRAVITREAL BEVACIZUMAB ADMINISTRATION FOR IDIOPATHIC CHOROIDAL NEOVASCULARIZATION [J].
Inoue, Maiko ;
Kadonosono, Kazuaki ;
Watanabe, Yoichiro ;
Sato, Shimpei ;
Kobayashi, Satoshi ;
Yamane, Shin ;
Ito, Rieko ;
Arakawa, Akira .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2010, 30 (05) :733-738
[18]   Bilateral serous retinal detachment resembling central serous chorioretinopathy following epidural steroid injection [J].
Kao, LY .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 1998, 18 (05) :479-481
[19]   Central serous chorioretinopathy after local application of glucocorticoids for skin disorders [J].
Karadimas, P ;
Kapetanios, A ;
Bouzas, EA .
ARCHIVES OF OPHTHALMOLOGY, 2004, 122 (05) :784-786
[20]   The efficacy of intravitreal bevacizumab for idiopathic central serous chorioretinopathy [J].
Lim, Ji Won ;
Kim, Min Uk .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2011, 249 (07) :969-974